tirzepatide shortage fda update Update: On December 19th the ruled the tirzepatide was resolved, however is giving a grace period for compounding pharmacies to continuing manufacturing. This grace period is 60 days. On FDA says shortage of GLP-1

For insurers, the problem with GLP-1s is their large budgetary impact, sometimes referred to as financial exposure, should they cover them

Your risk for getting low blood sugar may be higher if you use Zepbound with medicines that can cause low blood sugar, such as a sulfonylurea or insulin

With additional trials ongoing (TRIUMPH-2 and TRIUMPH-3), Retatrutide's anticipated approval could bring state-of-the-art weight management to Flower Mound by 2028

Learn your migraine triggers People who experience migraines often have specific triggers that are unique to them, such as bright lights, loud noise, intense heat, or too much caffeine or alcohol